NEW YORK (GenomeWeb News) — Aryx Therapeutics will use GenomeQuest’s sequence search service for use in intellectual property research related to its retrometabolic drug studies, GenomeQuest said today.
 
GenomeQuest’s software is used by researchers and IP lawyers to evaluate the patentability and competitive landscape for gene sequences.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.